Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
Randomized Trial of Recruitment Strategies for Early Phase Therapeutic Cancer Trials
Sponsor: Stand Up To Cancer
Listed as NCT05886764, this observational or N/A phase trial focuses on Cancer and Malignancy and remains ongoing. Sponsored by Stand Up To Cancer, it has been updated 9 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Apr 28, 2026 — Present [daily]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting · Phase: NA → None
-
Mar 2026 — Apr 2026 [monthly]
Recruiting NA
-
Jul 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Jul 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jun 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2023 — Feb 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2023 — Sep 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).
Contact Information
- Stand Up To Cancer
- University of Chicago
For direct contact, visit the study record on ClinicalTrials.gov .